UnitedHealth Group Incorporated (UNH) Shares Bought by Howe & Rusling Inc.
Howe & Rusling Inc. raised its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 8,795.9% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 25,798 shares of the healthcare conglomerate’s stock after purchasing an additional 25,508 shares during the quarter. Howe & Rusling Inc.’s holdings in UnitedHealth Group were worth $5,053,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently bought and sold shares of the business. Harbour Capital Advisors LLC lifted its holdings in shares of UnitedHealth Group by 18,383.4% in the 2nd quarter. Harbour Capital Advisors LLC now owns 2,516,706 shares of the healthcare conglomerate’s stock valued at $13,573,000 after buying an additional 2,503,090 shares during the period. Janus Henderson Group PLC lifted its holdings in shares of UnitedHealth Group by 1,820.1% in the 2nd quarter. Janus Henderson Group PLC now owns 2,388,641 shares of the healthcare conglomerate’s stock valued at $442,896,000 after buying an additional 2,264,242 shares during the period. Vanguard Group Inc. lifted its holdings in shares of UnitedHealth Group by 2.5% in the 2nd quarter. Vanguard Group Inc. now owns 64,578,618 shares of the healthcare conglomerate’s stock valued at $11,974,168,000 after buying an additional 1,588,516 shares during the period. Parametric Portfolio Associates LLC lifted its holdings in shares of UnitedHealth Group by 77.3% in the 2nd quarter. Parametric Portfolio Associates LLC now owns 3,584,134 shares of the healthcare conglomerate’s stock valued at $664,570,000 after buying an additional 1,562,661 shares during the period. Finally, Jennison Associates LLC lifted its holdings in shares of UnitedHealth Group by 180.4% in the 2nd quarter. Jennison Associates LLC now owns 2,252,507 shares of the healthcare conglomerate’s stock valued at $417,660,000 after buying an additional 1,449,130 shares during the period. Institutional investors and hedge funds own 86.20% of the company’s stock.
In other UnitedHealth Group news, insider Thomas E. Roos sold 975 shares of the stock in a transaction that occurred on Thursday, October 19th. The stock was sold at an average price of $205.47, for a total transaction of $200,333.25. Following the completion of the transaction, the insider now owns 24,630 shares of the company’s stock, valued at $5,060,726.10. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Michele J. Hooper sold 5,000 shares of the stock in a transaction that occurred on Monday, December 4th. The shares were sold at an average price of $222.20, for a total value of $1,111,000.00. Following the transaction, the director now directly owns 36,989 shares of the company’s stock, valued at approximately $8,218,955.80. The disclosure for this sale can be found here. Insiders have sold 12,032 shares of company stock valued at $2,658,310 in the last three months. Insiders own 0.89% of the company’s stock.
UnitedHealth Group Incorporated (UNH) traded up $0.57 during midday trading on Friday, reaching $221.82. The company had a trading volume of 5,901,705 shares, compared to its average volume of 2,766,697. The firm has a market cap of $214,958.67, a PE ratio of 23.11, a price-to-earnings-growth ratio of 1.65 and a beta of 0.66. UnitedHealth Group Incorporated has a 12 month low of $156.09 and a 12 month high of $231.77. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.52.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share for the quarter, topping analysts’ consensus estimates of $2.57 by $0.09. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. The company had revenue of $50.32 billion during the quarter, compared to analysts’ expectations of $50.38 billion. During the same quarter in the prior year, the firm posted $2.17 EPS. UnitedHealth Group’s quarterly revenue was up 8.7% compared to the same quarter last year. equities analysts anticipate that UnitedHealth Group Incorporated will post 9.99 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which was paid on Tuesday, December 12th. Shareholders of record on Friday, December 1st were issued a dividend of $0.75 per share. The ex-dividend date was Thursday, November 30th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.35%. UnitedHealth Group’s payout ratio is currently 33.26%.
COPYRIGHT VIOLATION WARNING: “UnitedHealth Group Incorporated (UNH) Shares Bought by Howe & Rusling Inc.” was posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece of content on another publication, it was copied illegally and republished in violation of US and international trademark and copyright laws. The legal version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/12/17/unitedhealth-group-incorporated-unh-shares-bought-by-howe-rusling-inc.html.
UnitedHealth Group Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).
Receive News & Stock Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related stocks with our FREE daily email newsletter.